Aug. 21, 2012
Bernstein Liebhard LLP is investigating whether the Board of Directors of Coventry Health Care, Inc. (“Coventry” or the “Company”) (NYSE: CVH) breached its fiduciary duty to its shareholders in agreeing to sell Coventry to Aetna Inc. (NYSE: AET).
Under the terms of the agreement, Coventry shareholders will receive $27.30 in cash and 0.3885 Aetna common shares for each share they own. The investigation is focused on the potential unfairness of the price to Coventry shareholders and the process by which the Coventry Board of Directors considered and approved the transaction.
If you are interested in discussing your rights as a Coventry stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at: (877) 779-1414 or Ottensoser@bernlieb.com.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last nine years.